Stay updated on Nivolumab for IDH Mutant Gliomas Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for IDH Mutant Gliomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for IDH Mutant Gliomas Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page now includes a consolidated Locations section listing Florida, Massachusetts, and New York sites, replacing the previous separate location pages for these sites.
    Difference
    0.4%
    Check dated 2025-12-22T22:38:02.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    A new citation is added in Publications: Snyder et al., 2014 NEJM on CTLA-4 blockade in melanoma. The Erratum reference for that paper is removed.
    Difference
    0.1%
    Check dated 2025-12-15T20:59:20.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added and v3.3.1 removed; this is a minor site maintenance update and does not alter study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T12:48:52.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    A bibliographic citation in the Publications section was added and an older version of the same citation was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T11:14:48.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The government funding/operating status notice is removed from the page; trial details, eligibility, and outcomes remain the same.
    Difference
    0.4%
    Check dated 2025-11-17T06:11:28.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    The page now includes posted results (Results First Posted/Submitted) and a new PDF for the Study Protocol and SAP; enrollment and completion dates are updated and the study status is now Completed.
    Difference
    2%
    Check dated 2025-11-10T01:59:50.000Z thumbnail image

Stay in the know with updates to Nivolumab for IDH Mutant Gliomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for IDH Mutant Gliomas Clinical Trial page.